Latus Bio Secures $42 Million for Huntington's Disease Gene Therapy Trial
Latus Bio has successfully raised $42 million to advance its gene therapy aimed at treating Huntington's disease, with plans to seek FDA approval for a clinical trial.
Courts, regulation, legal affairs, privacy, and corporate law.
Latus Bio has successfully raised $42 million to advance its gene therapy aimed at treating Huntington's disease, with plans to seek FDA approval for a clinical trial.
A recent federal appeals court ruling has determined that mifepristone, a medication used in the majority of abortions in the U.S., can now only be distributed in person at clinics.
The Center for Biological Diversity is urging an appeals court to review the contentious transfer of Oak Flat land in Arizona, citing environmental concerns.
The principle of 'location, location, location' holds significant weight in social media, influencing how users perceive posts that include geographic details.
The X-ray Pump Probe (XPP) instrument at SLAC's Linac Coherent Light Source is operational again after a comprehensive rebuild, allowing researchers to conduct advanced experiments.
A study from James Cook University investigates the effects of rap-related cues on jury judgments, prompting discussions about the role of lyrics as evidence in legal settings.
AstraZeneca is set to expand its research and development operations in the U.K. following a favorable trade agreement with the U.S., as the Supreme Court hears arguments on 'skinny labels' in pharmaceuticals.
During a recent session, Supreme Court justices indicated that they may not challenge the validity of skinny labeling, suggesting potential support for its continuation.
The Supreme Court has temporarily halted the Trump administration's deportation efforts affecting thousands of migrants with Temporary Protected Status, including many Haitians and Syrians.
The FDA is taking steps to accelerate clinical trials by reviewing data in real time, while the Supreme Court prepares to hear a pivotal case on 'skinny labels'.
David Morens, an adviser to Dr. Anthony Fauci, faces indictment for allegedly concealing emails and evading records requests, linked to inquiries about the origins of COVID-19.
The Supreme Court is set to hear arguments regarding skinny labeling, a practice that may affect the accessibility of generic medications in the market.
The Supreme Court's deliberation on Roundup lawsuits may have significant consequences for Bayer, as it faces thousands of claims related to cancer risks associated with its product.
Cole Allen has been charged with the attempted assassination of former President Trump, as the White House responds by attributing blame to critics for the current political climate.
Motif Neurotech has received FDA approval to commence an initial feasibility trial for a brain implant aimed at treating depression, marking a significant step in neurotechnology.
In the aftermath of a shooting incident at the White House Correspondents' Dinner, President Trump addresses the media, linking the event to his call for a new ballroom.
A recent shooting incident marks the third assassination attempt on former President Trump in less than two years, highlighting ongoing security challenges.
Senator Thom Tillis has changed his stance, allowing Kevin Warsh's nomination as Fed chair to move forward after previously threatening to block it until a criminal probe into Jay Powell was resolved.
A recent court ruling in Nova Scotia has overturned a wildfire prevention ban, siding with a hiker who challenged the order. The decision raises questions about what constitutes 'woods.'
Gannon Ken Van Dyke is charged with using classified information to profit from bets on Nicolás Maduro's removal, potentially facing a lengthy prison sentence.